MedinCell is a pharmaceutical company based in France that develops long-acting injectable medicines. Its technology forms tiny deposits in the body that release a drug steadily over time, which can help patients take their treatment less often. The company works with pharmaceutical partners to develop these products and to bring them through clinical testing and to market. Its work covers several therapeutic areas, including treatments for serious and chronic conditions.
MedinCell trades under the code 0ACH on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2818 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
45/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average6.5%
From 52-week high-31.0%
MomentumWeak
45/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-0.3%
6-month return12.5%
12-month, skipping last month-36.3%
Stability (higher is calmer)Weak
24/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)53.9%
Worst drawdown, 1 year (smaller is calmer)-45.4%
LiquidityWeak
27/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.07M EUR
Zero-volume days1.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 19.69 – 39.38Daily closes, split-adjusted
Signals
50-day average24.24
200-day average24.81
Golden/death cross (60d)Death, 32 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.22
Technical summary
Daily
Strongly bullish
11 bullish · 4 neutral · 1 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
5 bullish · 1 neutral · 1 bearish
Moving averages (daily)
SMA 10
26.17
Bullish
EMA 10
26.13
Bullish
SMA 20
25.84
Bullish
EMA 20
25.69
Bullish
SMA 50
24.24
Bullish
EMA 50
24.99
Bullish
SMA 100
25.16
Bullish
EMA 100
24.94
Bullish
SMA 200
24.81
Bullish
EMA 200
24.66
Bullish
Oscillators (daily)
RSI (14)
54.78
Neutral
MACD (12, 26)
0.63
Bullish
Momentum (12)
-9.98
Bearish
Stochastic %K (14)
25.72
Neutral
Williams %R (14)
-74.28
Neutral
CCI (20)
24.60
Neutral
Pivot points (classic, last session)
S3
26.25
S2
26.28
S1
26.36
Pivot
26.39
R1
26.47
R2
26.50
R3
26.58
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
